We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBA icon
2076
Ambarella
AMBA
$3.64B
$170K ﹤0.01%
3,024
-64
-2% -$4.74K
BRZE icon
2077
Braze
BRZE
$3.18B
$170K ﹤0.01%
+4,868
New +$206K
IEP icon
2078
Icahn Enterprises
IEP
$5.39B
$170K ﹤0.01%
3,430
+1,956
+133% +$101K
SAND
2079
DELISTED
Sandstorm Gold
SAND
$170K ﹤0.01%
32,694
+26,942
+468% +$157K
SEM
2080
DELISTED
Select Medical
SEM
$170K ﹤0.01%
14,308
+5,841
+69% +$83K
SPYD icon
2081
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.7B
$170K ﹤0.01%
+4,813
New +$194K
VNDA icon
2082
Vanda Pharmaceuticals
VNDA
$298M
$170K ﹤0.01%
17,185
-5,939
-26% -$62.7K
BBT
2083
Beacon Financial Corp
BBT
$2.66B
$169K ﹤0.01%
6,207
+4,568
+279% +$127K
ING icon
2084
ING
ING
$101B
$169K ﹤0.01%
19,860
+19,360
+3,872% +$180K
OBK icon
2085
Origin Bancorp
OBK
$1.66B
$169K ﹤0.01%
4,380
+3,623
+479% +$150K
PR
2086
Permian Resources
PR
$18B
$169K ﹤0.01%
24,873
-744
-3% -$5.14K
RVLV icon
2087
Revolve Group
RVLV
$1.69B
$169K ﹤0.01%
7,766
-1,977
-20% -$52K
SGMO
2088
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$169K ﹤0.01%
34,414
+2,662
+8% +$13.7K
IRBT
2089
DELISTED
iRobot
IRBT
$168K ﹤0.01%
2,991
+868
+41% +$45.6K
MATV icon
2090
Mativ Holdings
MATV
$706M
$168K ﹤0.01%
7,276
+5,863
+415% +$134K
PRGS icon
2091
Progress Software
PRGS
$1.77B
$168K ﹤0.01%
3,956
+2,303
+139% +$106K
RAPT
2092
DELISTED
RAPT Therapeutics
RAPT
$168K ﹤0.01%
872
+711
+442% +$134K
RNAM
2093
DELISTED
Avidity Biosciences
RNAM
$168K ﹤0.01%
10,286
-727
-7% -$13.9K
WWD icon
2094
Woodward
WWD
$21.1B
$168K ﹤0.01%
2,097
-2,143
-51% -$202K
YORW icon
2095
York Water
YORW
$527M
$168K ﹤0.01%
4,374
+1,924
+79% +$82.5K
BBIO icon
2096
BridgeBio Pharma
BBIO
$16.4B
$167K ﹤0.01%
16,795
-16,018
-49% -$166K
CASH icon
2097
Pathward Financial
CASH
$1.82B
$167K ﹤0.01%
5,081
-131
-3% -$4.71K
EVR icon
2098
Evercore
EVR
$11.7B
$167K ﹤0.01%
2,033
-444
-18% -$42K
GSBC icon
2099
Great Southern Bancorp
GSBC
$875M
$167K ﹤0.01%
2,937
-4,164
-59% -$251K
LAND
2100
Gladstone Land Corp
LAND
$354M
$167K ﹤0.01%
9,248
+7,105
+332% +$166K
82 83
84
85 86

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.